Axsome Therapeutics, Inc. (AXSM) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 8.91B USD. 52-week range 119.20 to 260.19 USD. Data as of 2026-10-09.
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine ...